The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Terminal rate repricing might not be over

Mon, 09th Jan 2023 10:55

STOXX 600 up 0.4%

*

China reopening lifts mood

*

U.S. stock futures edge higher

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

TERMINAL RATE REPRICING MIGHT NOT BE OVER (1051 GMT)

On December 15, probably showing dissatisfaction at the 'low' terminal rate pricing at around 3%, the ECB said there needed to be more hikes to bring rates to more restrictive levels.

Now, money markets show a peak at about 3.5% in summer 2023, but the big unknown is if the central bank will need to further tighten financial conditions.

UBS analysts crunched some numbers and found differences between the Fed and the ECB in their implied real policy rates.

"Compared to the Fed's ambition of reaching and preserving a sufficiently restrictive stance, even after the current repricing in terminal rates, real ECB policy rate would stay firmly negative in '23 and turn marginally positive by '24 and '25," Rohan Khanna, a rate strategist at UBS, says.

"All else equal and taking ECB's inflation forecasts at face value, this would call for terminal rate pricing having to rise even further in the near term," he adds.

When comparing real yields, which seems to be the ECB's preferred metric, euro area real GDP-weighted sovereign yields are negative at shorter maturities and positive beyond the 5-year point.

"While the scarcity of nominal cash European government bonds (especially Bunds) is a factor driving this 'richness', the ECB may still conclude that financing conditions are accommodative and need further tightening," he says.

EURO STOXX AT 8-MONTH HIGH (0940 GMT)

European shares got off to a positive start on Monday with many indices hitting fresh highs or trading very close to those levels.

China's reopening and optimism over slower rate hikes in the U.S. are keeping investors upbeat as the new year gets underway.

A STOXX gauge of euro zone stocks rose to its highest since end April 2022, and was last up 0.4%, while the broader pan-regional STOXX 600 equity benchmark added 0.5%, close to hitting May 2022 levels.

The UK's FTSE 100 was just a whisker below its highest since August 2018, up 0.1%, while the IBEX in Spain, whose banks are the most exposed to Brazil, lagged, down 0.1%. Here's your opening snapshot:

EUROPE SET TO EXTEND NEW YEAR RALLY (0749 GMT)

European shares are set to open higher on the second week of 2023, boosted by growing optimism over China's reopening and following Friday's rally on Wall Street on the back of jobs data easing rate hike worries.

Euro STOXX 50 futures were last up 0.6% after hitting their highest since February 2022, while FTSE and DAX futures gained 0.2 and 0.5%, respectively. In Asia, stocks rallied on hopes for a less aggressive Federal Reserve, while U.S. stock futures inched higher.

On the corporate front, focus will be on AstraZeneca after the UK drugmaker agreed to buy U.S.-based CinCor Pharma in a $1.8 billion deal to strengthen its pipeline of heart and kidney drugs. Vodafone will also be in the spotlight after saying it was set to cash in 1.7 billion euros from the sale of its Hungarian unit.

Videgoame stocks Frontier Developments and Devolver Digital are expected to fall sharply following disappointing trading updates. Keller is also seen under heavy pressure after the engineering contractor reported a financial reporting fraud in its Austral Business unit in Australia.

GOODBYE TO ALL THAT (0711 GMT)

After three years, travellers are streaming into China by air, land and sea. Long lines snaked through checkpoints at the Hong Kong border. Ferries to Macau swelled with passengers.

"Life is moving forward again!" the official newspaper of the Chinese Communist Party, the People's Daily, wrote on Sunday.

"Today, the virus is weak, we are stronger."

For now, markets are too. MSCI's Asia ex-Japan index jumped 2% to a six-month high. The yuan punched through its 200-day moving average to its highest since August, and the dollar was in retreat wherever Chinese tourists are expected.

Meanwhile another farewell came from Jack Ma, who is giving up control of fintech giant Ant Group, setting off gains in a number of Ma-related companies, principally Alibaba, as investors reckon it draws a line under regulators' attention.

Sentiment also got a boost last week from a benign blend of solid U.S. payroll gains and slower wage growth, combined with a sharp fall in service-sector activity. The twin hopes, then, of a gentler Fed and reviving China are holding recession fears at bay.

Fed fund futures now imply around a 25% chance of a half-point hike in February, down from around 50% a month ago, and focus is now an appearance by Fed Chair Jerome Powell on Tuesday and U.S. consumer price data on Thursday.

Earnings season kicks off this week with the major U.S. banks. Before then, traders are looking to German industrial output data and European unemployment figures on Monday and appearances by Bank of England chief economist Huw Pill and Atlanta Fed President Raphael Bostic later in the day.

In emerging markets, focus is on the open of trade in the Brazilian real after hundreds of supporters of far-right former President Jair Bolsonaro were arrested during an invasion of the country's Congress, presidential palace and Supreme Court.

Key developments that could influence markets on Monday:

- Fed's Bostic and BOE's Pill speak

- Japan's PM Kishida meets with France's President Macron

- Euro zone unemployment (November)

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.